Intraocular Melanoma Unknown Status Phase 2 Trials for Bevacizumab (DB00112)

Also known as: Intraocular melanoma NOS

IndicationStatusPhase
DBCOND0028574 (Intraocular Melanoma)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01217398Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the EyeTreatment